Cem Akin, MD, PhD
AIM Vice President
University of Michigan Division of Allergy and Immunology
Dr. Akin is a clinician-scientist and a Professor of Medicine at the University of Michigan Division of Allergy and Immunology. He obtained his Internal Medicine training and PhD in Microbiology and Immunology from University of Louisville, and completed his fellowship at NIAID, NIH in Allergy and Clinical Immunology.
Dr. Akin is recognized for his work on mast cell disorders including mastocytosis, mast cell activation syndromes, and anaphylaxis. As an Associate Professor at Harvard Medical School, he established the first multidisciplinary mastocytosis center at Brigham and Women’s Hospital. His clinical interests include tyrosine kinase inhibitor and other novel treatments for indolent systemic mastocytosis, tryptase and other biomarkers for mast cell disease, and pathophysiology and treatment of anaphylaxis.
Dr. Akin is a co-author of the current WHO diagnostic criteria and classification of mastocytosis and has published over 20 scientific papers and book chapters on mastocytosis. He was awarded the Researcher of the Year and the ECNM Medal and Trophy in 2022 by European Competence Network on Mastocytosis. He served on the editorial boards of JACI and Blood, is a past President of the Michigan Allergy Society, and currently enjoys teaching fellows, conducting clinical research, and seeing a diverse population of allergy patients at the University of Michigan.